SARS-CoV-2 Vaccine Effectiveness 66 Percent During Delta Predominance
Vaccine effectiveness for all three vaccines decreased from 91 percent in months preceding delta predominance.
Diagnosis & Disease Information
FDA Warns Against ‘Off-Label’ Use of Pfizer COVID-19 Vaccine in Younger Children
Adult vaccine dose is much higher than doses being tested in younger children.
mRNA Vaccine Effective Against Hospitalization Over 24-Week Period
Pfizer-BioNTech and Moderna vaccines effective against COVID-19-associated hospitalizations among adults
COVID-19 Immune Response Appears Strong in Cancer Patients
Vast majority show seropositivity four months after the second COVID-19 vaccine dose.
FDA Grants First Full Approval to Pfizer-BioNTech COVID-19 Vaccine
The approval is indicated for individuals 16 years of age and older, however the vaccine remains available to those aged 12 years and older under the EUA.
Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used.
COVID-19 Booster Shots for All Americans, Starting Sept. 20
The plan calls for Americans to get a booster shot 8 months after their second dose.
FDA Okays COVID-19 Vaccine Booster Shot for Immunocompromised Patients
An appropriate vaccination strategy will follow.
Incidence of Axillary Adenopathy After COVID-19 Vaccination May Be Lower Than Previously Thought
Prior data suggested the incidence may be as high as 16%.
All Health Care, Long-Term Care Workers in California Must Get COVID-19 Shots
Order issued as the most populous state in the country struggles to slow infections caused by the highly contagious delta variant.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...